Human Genome Sciences Inc.

Quick facts

Marketed products

• Lymphostat B · Oncology · revenue 1100
  Belimumab works by blocking the B Lymphocyte Stimulator, a protein that can contribute to the autoimmune response in Systemic lupus erythematosus.

Phase 3 pipeline

• albumin interferon alfa-2b · Oncology
  Albumin interferon alfa-2b is a recombinant form of interferon alfa-2b fused to human albumin, which is used to enhance its half-life and therapeutic effects.

Phase 2 pipeline

• Albuferon · Other
• PEG-IFNalfa2a

Phase 1 pipeline

• Single Dose Group: Belimumab SC 1 x 200 mg

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Human Genome Sciences Inc. portfolio CI brief
• Human Genome Sciences Inc. pipeline updates RSS